Wellbeing Digital Sciences (formerly Ketamine One) is a mental healthcare and wellness company with a key focus on ketamine-enhanced therapy and psychedelic medicines. It has healthcare clinics across North America that aim to offer its patients transformational experiences and heal their “physical or emotional pain” using advanced psychedelic therapy research.
Wellbeing Digital Sciences
Their aim is to make mental health care including plant medicine and psychedelics more accessible to patients. They are building critical infrastructure for breakthrough and life-changing mental wellness treatments through their clinics, experienced professionals, and using advanced technology.
They are doing this via 1) Clinical Care, 2) Wearable Technology, and 3) Contract Research.
Wellbeing Digital Sciences operates a number of healthcare clinics across North America. The company are developing wearable technologies to track patient information before, during and after they have received ketamine-assisted therapy. Ketamine One has an exclusive agreement with Canadas largest private-sector union, Unifor, to provide its 315,000 members access to ketamine-assisted therapies.
Subsidiaries
- KGK Science is contract research company has extensive experience in pharmaceuticals, cannabis, natural health products, and more recently psychedelics. The company is wholly owned by Wellbeing Digital Sciences.
Explore more company info with a Tree membership
📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates
Company News
Ketamine One says it intends to submit a draft registration statement for a proposed US IPO (, 06 February 2025)Ketamine One says wholly-owned subsidiary, IRP Health recently opened two veteran-focused and multidisciplinary clinics in Comox Valley and Ottawa (, 16 November 2021)
Ketamine One Provides Second Update on Management Cease Trade Order (, 29 November 2021)
Ketamine One Teams Up With Cognetivity Neurosciences To Study PTSD, Depression (, 02 December 2021)
Ketamine One adds Seattle location to its expanding US clinical network (, 08 December 2021)